Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
10 hedge funds and large institutions have $1.06M invested in Genetic Technologies Ltd. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more funds holding
Funds holding: 8 → 10 (+2)
64% less capital invested
Capital invested by funds: $2.98M → $1.06M (-$1.92M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.9K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$20.4K |
| 3 |
Citigroup
New York
|
+$107 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$609K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$225K |
| 3 |
Millennium Management
New York
|
-$208K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$46.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $683K | -$609K | -11,350 | -37% |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $268K | -$536 | -10 | -0.1% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $40K | -$225K | -4,190 | -79% |
|
|
4
Citadel Advisors
Miami,
Florida
| $23K | -$4.29K | -80 | -11% |
|
|
5
Creative Planning
Overland Park,
Kansas
| $14K | +$20.4K | +380 | New |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $13K | +$20.9K | +390 | New |
|
7
Morgan Stanley
New York
| $8K | -$2.74K | -51 | -19% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $6K | -$46.8K | -873 | -84% |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $5K | – | – | – |
|
|
10
Millennium Management
New York
| – | -$208K | -3,427 | Closed |
|
|
11
Citigroup
New York
| – | +$107 | +2 | New |
|
GENE Hedge Fund Activity: Q3 2015 in Review
10 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2015, worth a combined $1.06M — down 64% from $2.98M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GENE positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 6 trimmed.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $20.9K. The largest seller was Renaissance Technologies, cutting an estimated $609K.
- 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2015, up from 8 in Q2 2015.
- Funds reported $1.06M of Genetic Technologies Ltd. stock for Q3 2015, down 64% quarter-over-quarter.
- 3 funds opened new Genetic Technologies Ltd. positions in Q3 2015 and 1 closed out, a net change of +2 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2015 was Deutsche Bank, an estimated $20.9K added.
- The largest Genetic Technologies Ltd. seller in Q3 2015 was Renaissance Technologies, an estimated $609K sold.
Based on aggregated 13F filings for Q3 2015.